Journal of Clinical Endocrinology & Metabolism, Vol 64, 657-660, Copyright © 1987 by Endocrine Society

ARTICLES

The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone

G Baumann, KD Amburn and TA Buchanan

We recently described a specific binding protein for human GH (hGH) in human plasma, with which a substantial portion of circulating hGH is complexed. The biological function of the complexed fraction is unknown. To test the hypothesis that complexed hGH may have different in vivo kinetics than free hGH, we compared the MCRs, distribution volumes (Vd), and degradation rates of complexed and free [125I] hGH in the rat. A partially purified GH-binding protein preparation, generated by affinity chromatography on a hGH column, was used for this purpose. A mixture of hGH with binding protein (equivalent to the amount contained in 0.9 mL human plasma) was injected iv as a single dose. Parallel experiments were conducted with hGH in the absence of binding protein. Disappearance of total, immunoprecipitable, and trichloroacetic acid-precipitable radioactivity from rat plasma was followed, and MCR, Vd, and degradation rates were derived by standard mathematical techniques. The MCR was 6-fold slower for complexed than for free hGH (2.3 vs. 14 mL/min X kg), Vd was 4-fold smaller for complexed hGH than for free hGH (71 vs. 256 mL/kg), and initial degradation rate was 4.5-fold lower for complexed than for free hGH (13.2% vs. 59.9%/15 min). The Vd of complexed hGH was close to the intravascular volume, while the Vd for free hGH corresponded to the extracellular volume. We conclude that one function of the hGH-binding protein is relative confinement of hGH to the vascular compartment, thereby protecting it from degradation and prolonging its biological half-life.

This article has been cited by other articles:

				C. E. Bowles, I. Wilkinson, R. A. G. Smith, A. J. G. Moir, H. Montgomery, and R. J. M. Ross Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor Endocrinology, February 1, 2007; 148(2): 824 - 830. [Abstract] [Full Text] [PDF]

				J. Fuglsang, P. Sandager, N. Moller, S. Fisker, H. Orskov, and P. Ovesen Kinetics and secretion of placental growth hormone around parturition. Eur. J. Endocrinol., March 1, 2006; 154(3): 449 - 457. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]

				T. K. Hansen, C. H. Gravholt, H. Orskov, M. H. Rasmussen, J. S. Christiansen, and J. O. L. Jorgensen Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4691 - 4698. [Abstract] [Full Text] [PDF]

				T. K. Hansen, J. O. L. Jorgensen, and J. S. Christiansen Body Composition and Circulating Levels of Insulin, Insulin-Like Growth Factor-Binding Protein-1 and Growth Hormone (GH)-Binding Protein Affect the Pharmacokinetics of GH in Adults Independently of Age J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2185 - 2193. [Abstract] [Full Text] [PDF]

				W. C. Hymer, W. J. Kraemer, B. C. Nindl, J. O. Marx, D. E. Benson, J. R. Welsch, S. A. Mazzetti, J. S. Volek, and D. R. Deaver Characteristics of circulating growth hormone in women after acute heavy resistance exercise Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E878 - E887. [Abstract] [Full Text] [PDF]

				B. C. Nindl, W. C. Hymer, D. R. Deaver, and W. J. Kraemer Growth hormone pulsatility profile characteristics following acute heavy resistance exercise J Appl Physiol, July 1, 2001; 91(1): 163 - 172. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. Jiang, R. A. Black, G. Baumann, and S. J. Frank Tumor Necrosis Factor-{{alpha}} Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation Endocrinology, December 1, 2000; 141(12): 4342 - 4348. [Abstract] [Full Text] [PDF]

				K.-C. Leung, N. Doyle, and K. K. Y. Ho Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum Endocrinology, January 1, 2000; 141(1): 138 - 145. [Abstract] [Full Text] [PDF]

				J. G. Langendonk, A. E. Meinders, J. Burggraaf, M. Frolich, C. A. M. Roelen, R. C. Schoemaker, A. F. Cohen, and H. Pijl Influence of obesity and body fat distribution on growth hormone kinetics in humans Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E824 - E829. [Abstract] [Full Text] [PDF]

				G. M. Bright, J. D. Veldhuis, A. Iranmanesh, G. Baumann, H. Maheshwari, and J. Lima Appraisal of Growth Hormone (GH) Secretion: Evaluation of a Composite Pharmacokinetic Model That Discriminates Multiple Components of GH Input J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3301 - 3308. [Abstract] [Full Text]

				A. Edens and F. Talamantes Alternative Processing of Growth Hormone Receptor Transcripts Endocr. Rev., October 1, 1998; 19(5): 559 - 582. [Abstract] [Full Text]

				M. Tzanela, C. Wagner, and G. Shaffer Tannenbaum Recombinant Human Growth Hormone-Binding Protein Fails to Enhance the in Vivo Bioactivity of Human Growth Hormone in Normal Rats Endocrinology, December 1, 1997; 138(12): 5316 - 5324. [Abstract] [Full Text] [PDF]

				S. I. Ymer, J. L. Stevenson, and A. C. Herington Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity Endocrinology, September 1, 1997; 138(9): 3577 - 3586. [Abstract] [Full Text] [PDF]

				L. Baumbach, A. Schiavi, R. Bartlett, E. Perera, J. Day, M. R. Brown, S. Stein, M. Eidson, J. S. Parks, and W. Cleveland Clinical, Biochemical, and Molecular Investigations of a Genetic Isolate of Growth Hormone Insensitivity (Laron's Syndrome) J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 444 - 451. [Abstract] [Full Text] [PDF]

				F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF]

				R. Clark, K. Olson, G. Fuh, M. Marian, D. Mortensen, G. Teshima, S. Chang, H. Chu, V. Mukku, E. Canova-Davis, et al. Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol J. Biol. Chem., September 6, 1996; 271(36): 21969 - 21977. [Abstract] [Full Text] [PDF]

				Y. Takahashi, H. Kaji, Y. Okimura, K. Goji, H. Abe, and K. Chihara Short Stature Caused by a Mutant Growth Hormone N. Engl. J. Med., February 15, 1996; 334(7): 432 - 436. [Full Text] [PDF]

				J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF]

				Y. Zhang, R. Guan, J. Jiang, J. J. Kopchick, R. A. Black, G. Baumann, and S. J. Frank Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis J. Biol. Chem., June 29, 2001; 276(27): 24565 - 24573. [Abstract] [Full Text] [PDF]